Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/21/2003CA2182289C Immuno-stimulatory monoclonal antibodies
10/21/2003CA2157659C Use of porcine gal .alpha. (1,3) galactosyl transferase in xenograft therapies
10/21/2003CA2156825C Inhibition of intimal hyperplasia using antibodies to pdgf receptors
10/21/2003CA2132452C Casein kinase i-like protein kinase
10/21/2003CA2115049C Dna sequences encoding gelonin polypeptide
10/21/2003CA2106962C Polypeptides from mycobacterium paratuberculosis
10/21/2003CA2076432C Humanized antibody derivatives that recognize difucosyl lewis blood group antigens y-6 and b-7-2
10/21/2003CA2072649C Methods and materials for expression of human plasminogen variant
10/21/2003CA2066940C Canine coronavirus subunit vaccine
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
10/21/2003CA2017166C Metalloproteinase inhibitor
10/21/2003CA1341445C Improved t-pa lacking the first kringle domain
10/21/2003CA1341444C Modified tissue plasminogen activator
10/16/2003WO2003085752A2 Molehole embedded 3-d crossbar architecture used in electrochemical molecular memory device
10/16/2003WO2003085405A1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085138A1 Methods of virus production
10/16/2003WO2003085137A1 Antisense modulation of liver glycogen phosphorylase expression
10/16/2003WO2003085135A1 New method
10/16/2003WO2003085134A2 Methods of diagnosing and treating colorectal cancer
10/16/2003WO2003085130A1 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
10/16/2003WO2003085125A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085118A1 Process for producing antibody composition
10/16/2003WO2003085117A1 Viral vectors comprising a nucleic sequence derived from murine leukemia viruses for gene transfer in cells
10/16/2003WO2003085116A1 Lentiviral vectors derived from sivsmm/pbj14, method for their production and uses thereof
10/16/2003WO2003085115A2 Identification and validation of novel targets for agrochemicals
10/16/2003WO2003085114A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
10/16/2003WO2003085113A1 Enhancer sequence of the 5-aminolevulinic acid synthase gene
10/16/2003WO2003085112A1 Enhancer sequence of the 5-aminolevulinic synthase gene
10/16/2003WO2003085111A1 Novel promoters
10/16/2003WO2003085110A2 Oligomeric compounds for the modulation hif-1alpha expression
10/16/2003WO2003085109A2 Method and apparatus for extracting nucleic acids from a complex mixture
10/16/2003WO2003085108A1 Recombinant dna having hydantoinase gene and carbamylase gene and process for producing amino acid
10/16/2003WO2003085106A1 Preventives and/or remedies for cancer
10/16/2003WO2003085105A1 A method for selecting cell lines to be used for nuclear transfer in mammalian species
10/16/2003WO2003085102A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport
10/16/2003WO2003085098A2 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti
10/16/2003WO2003085096A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085094A2 Solid phase methods for polynucleotide production
10/16/2003WO2003085091A2 Reversible association of nucleic acid with a carboxylated substrate
10/16/2003WO2003085090A2 A human ribonucleotide reductase m2 subunit
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003085087A2 Modified cea nucleic acid and expression vectors
10/16/2003WO2003085086A2 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003WO2003085084A2 Hepatitis c virus sub-genomic replicons
10/16/2003WO2003084996A2 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/16/2003WO2003084992A1 Novel proteins and dnas encoding the same
10/16/2003WO2003084989A2 La1 - the genome of a lactobacillus strain
10/16/2003WO2003084988A2 Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
10/16/2003WO2003084987A2 Polypeptides from bacteria and uses thereof
10/16/2003WO2003084986A2 Novel purified polypeptides involved in cellular metabolism
10/16/2003WO2003084982A2 Functionalized compositions for improved immobilization
10/16/2003WO2003084981A2 Phage display affinity and specificity filters and forward screen
10/16/2003WO2003084977A1 Gene expression control system and its use in recombinant virus packaging cell lines
10/16/2003WO2003084976A1 Process for isolating nucleic acid with chaotrope agents and ammonium compounds
10/16/2003WO2003084560A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003WO2003084478A2 Antisense modulation of hmgi-c expression
10/16/2003WO2003084472A2 Recombinant p. falciparum merozoite protein-142 vaccine
10/16/2003WO2003084471A2 Compositions selective for adenosine diphosphate and methods of using same
10/16/2003WO2003084467A2 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003WO2003084445A1 Device for mixing and/or injecting cements
10/16/2003WO2003084337A1 Triglyceride fat
10/16/2003WO2003084314A1 Plant with improved organogenesis and method of constructing the same
10/16/2003WO2003084312A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato
10/16/2003WO2003073238A3 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
10/16/2003WO2003072791A3 Transgenic fodder plants with an increased leaf starch content
10/16/2003WO2003070963A3 Improved protein expression in bacillus subtilis
10/16/2003WO2003070959A3 Process for producing levodione
10/16/2003WO2003068954A3 Microorganism for genetic therapeutic treatment of proliferative diseases
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003068809A3 An herpes simplex virus complex
10/16/2003WO2003066836A3 Udp-glucosyltransferases
10/16/2003WO2003065977A9 Modified antigen-presenting cells
10/16/2003WO2003064595A3 Recombinant herpesvirus of turkeys and use thereof
10/16/2003WO2003063792A8 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/16/2003WO2003062405A3 Method for inducing differentiation of embryonic stem cells
10/16/2003WO2003062397A3 Methods of increasing transformation frequency of maize
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003059935A3 Methods for purifying protein
10/16/2003WO2003059282A3 Human monoclonal antibodies against cd30
10/16/2003WO2003057863A3 Cloning methods and other methods of producing cells
10/16/2003WO2003057729A3 Mammal prolactin variants
10/16/2003WO2003056912A3 Inducible transposition in transgenic organism using transposon vector
10/16/2003WO2003056017A3 Alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said alkaline protease
10/16/2003WO2003054216A3 Antibodies that immunospecifically bind to trail receptors
10/16/2003WO2003051905A3 Taojiks as modifiers of the beta-catenin pathway and methods of use
10/16/2003WO2003048902A3 Library screening
10/16/2003WO2003048387A3 Labelled nucleotides
10/16/2003WO2003048344A3 Differentiation of human embryonic stem cells in avian embryos
10/16/2003WO2003048311A3 Regulated expression of recombinant dna
10/16/2003WO2003046162A3 Process for the production of polypeptides in mammalian cell cultures
10/16/2003WO2003044176A9 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
10/16/2003WO2003042356A3 Pttg knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
10/16/2003WO2003039555A3 Agents for treating lesions of the nervous system
10/16/2003WO2003037918A3 Pyranosone dehydratase from phanerochaete chrysosporium
10/16/2003WO2003037072A3 Promotion of somatic embryogenesis in plants by wuschel gene expression
10/16/2003WO2003035904A3 Methods and compositions to evaluate antibody treatment response
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003033660A3 9136, a human aldehyde dehydrogenase family member and uses therefor
1 ... 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 ... 4023